HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Takeshi Matsumoto Selected Research

Fibrin Fibrinogen Degradation Products

2/2016The efficacy of the administration of recombinant human soluble thrombomodulin in patients with DIC.
1/2014Elevated fibrin-related markers in patients with malignant diseases frequently associated with disseminated intravascular coagulation and venous thromboembolism.
10/2005Elevated plasma levels of fibrin degradation products by granulocyte-derived elastase in patients with disseminated intravascular coagulation.
1/2005Elevated plasma levels of fibrin degradation products by granulocyte-derived elastase in patients with deep vein thrombosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Takeshi Matsumoto Research Topics

Disease

18Disseminated Intravascular Coagulation
01/2020 - 07/2003
16Thrombosis (Thrombus)
09/2018 - 07/2003
12Neoplasms (Cancer)
09/2021 - 01/2003
11Hemorrhage
01/2021 - 02/2012
10Venous Thromboembolism
01/2021 - 04/2008
9Thrombotic Microangiopathies
01/2022 - 01/2008
9Venous Thrombosis (Deep-Vein Thrombosis)
05/2018 - 01/2005
8Obstructive Sleep Apnea
06/2021 - 01/2015
7Sleep Apnea Syndromes (Sleep Apnea)
01/2022 - 11/2018
7Hemophilia A (Haemophilia)
01/2020 - 11/2017
7Thrombotic Thrombocytopenic Purpura
01/2018 - 01/2007
6Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
02/2015 - 07/2013
5Thrombocytopenia (Thrombopenia)
12/2021 - 05/2009
5Apnea
05/2019 - 01/2015
5Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome)
09/2017 - 01/2011
5Interstitial Lung Diseases (Interstitial Lung Disease)
01/2017 - 04/2013
4Atypical Hemolytic Uremic Syndrome
01/2022 - 05/2012
4Cardiovascular Diseases (Cardiovascular Disease)
12/2021 - 12/2013
4Communicable Diseases (Infectious Diseases)
01/2019 - 08/2006
4Thrombophilia
10/2018 - 03/2012
4Infections
10/2017 - 04/2006
4Atherosclerosis
07/2015 - 12/2013
3Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune)
12/2021 - 01/2016
3Hypertension (High Blood Pressure)
12/2020 - 04/2019
3Hepatocellular Carcinoma (Hepatoma)
11/2020 - 03/2020
3Neoplasm Metastasis (Metastasis)
01/2019 - 06/2014
3Connective Tissue Diseases (Connective Tissue Disease)
09/2018 - 01/2016
3Sepsis (Septicemia)
02/2015 - 10/2005
3Pulmonary Embolism
10/2011 - 04/2008
2Hemolysis
01/2022 - 11/2018
2Type 2 Diabetes Mellitus (MODY)
01/2021 - 11/2019
2Hypoxia (Hypoxemia)
06/2020 - 01/2017
2Heart Arrest (Cardiac Arrest)
07/2019 - 06/2019
2Hyperemia
11/2018 - 01/2015
2Essential Hypertension
11/2018 - 04/2015
2Adenoma (Adenomas)
11/2018 - 04/2015
2Heart Failure
08/2018 - 04/2014
2Pathologic Constriction (Stenosis)
01/2018 - 08/2016
2Hemolytic-Uremic Syndrome
01/2018 - 11/2014
2Wounds and Injuries (Trauma)
04/2017 - 10/2005
2Diarrhea
01/2017 - 11/2014

Drug/Important Bio-Agent (IBA)

17Dacarbazine (DIC)FDA LinkGeneric
01/2019 - 07/2003
13Hemostatics (Antihemorrhagics)IBA
12/2021 - 07/2003
12FibrinIBA
10/2018 - 07/2003
9AntithrombinsIBA
10/2018 - 03/2012
8thiamine triphosphorate (TTP)IBA
01/2021 - 01/2007
8fibrin fragment D (D-dimer)IBA
09/2018 - 01/2005
7Fibrinogen (Factor I)FDA Link
06/2021 - 11/2008
6von Willebrand FactorIBA
09/2018 - 01/2008
5Biomarkers (Surrogate Marker)IBA
12/2021 - 12/2013
5Protein SIBA
10/2018 - 06/2010
5Fondaparinux (Arixtra)FDA Link
05/2016 - 10/2011
5rho-Associated KinasesIBA
10/2015 - 01/2014
5ErbB Receptors (EGF Receptor)IBA
02/2015 - 05/2013
4Adrenal Cortex Hormones (Corticosteroids)IBA
01/2022 - 01/2011
4Complement System Proteins (Complement)IBA
01/2022 - 11/2014
4Glucose (Dextrose)FDA LinkGeneric
01/2021 - 09/2012
4AnticoagulantsIBA
01/2020 - 10/2014
4ThrombinFDA Link
01/2020 - 10/2011
4Protein CIBA
10/2018 - 03/2012
4Fibrin Fibrinogen Degradation ProductsIBA
02/2016 - 01/2005
3eculizumabFDA Link
01/2022 - 01/2018
3Inosine Triphosphate (ITP)IBA
12/2021 - 01/2016
3Ethiodized Oil (Ethiodol)FDA Link
09/2021 - 03/2020
3Phospholipids (Phosphatides)FDA LinkGeneric
01/2020 - 07/2014
3Pharmaceutical PreparationsIBA
09/2019 - 01/2017
3Oxygen (Dioxygen)IBA
05/2019 - 11/2018
3formycin diphosphate (FDP)IBA
02/2016 - 11/2008
3Tyrosine Kinase InhibitorsIBA
02/2015 - 07/2013
3Paclitaxel (Taxol)FDA LinkGeneric
12/2014 - 01/2014
3Carboplatin (JM8)FDA LinkGeneric
12/2014 - 01/2014
3ThrombospondinsIBA
11/2014 - 01/2007
3DisintegrinsIBA
11/2014 - 01/2007
3Metalloproteases (Metalloproteinases)IBA
11/2014 - 01/2007
2Thromboplastin (Tissue Factor)IBA
12/2021 - 01/2021
2Blood Coagulation Factors (Coagulation Factor)IBA
10/2021 - 01/2020
2Anti-Bacterial Agents (Antibiotics)IBA
06/2021 - 04/2015
2Liposomes (Liposome)IBA
06/2021 - 09/2019
2GemcitabineFDA Link
06/2021 - 09/2019
2AntibodiesIBA
01/2021 - 07/2018
2edoxabanIBA
01/2021 - 01/2017
2Indicators and Reagents (Reagents)IBA
06/2020 - 04/2014
2Proteins (Proteins, Gene)FDA Link
06/2020 - 03/2017
2Lupus Coagulation Inhibitor (Lupus Anticoagulant)IBA
01/2020 - 10/2018
2Factor VIII (Coagulation Factor VIII)IBA
01/2020 - 07/2018
2emicizumabIBA
07/2019 - 11/2017
2AldosteroneIBA
11/2018 - 04/2015
2BilirubinIBA
11/2018 - 07/2012
2beta-cyclodextrin tetradecasulfate (CTDS)IBA
09/2018 - 09/2017
2Hypnotics and Sedatives (Sedatives)IBA
06/2017 - 01/2017
2platelet membrane glycoprotein VIIBA
04/2017 - 11/2014

Therapy/Procedure

12Therapeutics
01/2022 - 04/2008
8Orthopedic Procedures
01/2021 - 02/2012
4Knee Replacement Arthroplasty (Total Knee Replacement)
01/2021 - 10/2011
4Hip Replacement Arthroplasty (Total Hip Replacement)
01/2021 - 10/2011
4Continuous Positive Airway Pressure
01/2020 - 01/2016
3Drug Therapy (Chemotherapy)
01/2021 - 12/2014
3Liver Transplantation
04/2017 - 11/2009
2Transplantation
03/2022 - 07/2021
2Chemoradiotherapy
01/2019 - 05/2014